Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve To Consider and approve the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Transgene Biotek Ltd has informed BSE that its Board of Directors meeting is scheduled for May 29, 2026. The agenda includes consideration and approval of the Audited Financial Results (Standalone and Consolidated) for Q4 and the financial year ended March 31, 2026. Any other business matters may also be taken up with the Chair's permission. This is a standard pre-results announcement intimation. No actual financial figures or performance data have been disclosed in this filing.
This is a routine notice announcing an upcoming board meeting to approve annual results. The actual financial performance of the company for FY 2025-26 will be disclosed only after the meeting takes place. Shareholders should await the official results announcement expected after May 29, 2026 for any meaningful assessment of company performance.